All treatments
Treatment
BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
HOVON 146 ALL: Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. A phase II trial.
This study looks at a new way to treat a type of blood cancer called B-cell acute lymphoblastic leukaemia in adults. It's testing if adding a drug called Blincyto to standard treatment can help more patients get rid of tiny amounts of cancer cells after treatment.
For: Precursor B-acute lymphoblastic leukemiaBelgium · Netherlands - AuthorisedTherapeutic confirmatory (Phase III)
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
This study looks at new ways to treat children with a type of blood cancer called B-cell acute lymphoblastic leukaemia, which has come back after earlier treatment. It compares different drug combinations to find the most effective and safest options for them.
For: Relapsed Acute Lymphoblastic Leukemia (ALL)Netherlands · Czechia · Italy